Global Infertility Testing Market: Rising Cases of Gynecological Disorders Accelerates the Market Growth

Infertility Testing Market

Infertility is a condition in which a couple is unable to conceive. Testing for infertility is testing done to find out why a woman can't get pregnant. This makes it one of the most common diseases among people aged 20 to 45 years. There is infertility testing which is available for both male and female. Some of the factors which can cause infertility in women are problems in uterus, medical condition such as ovulation disorders, high level of cholesterol, and some drugs such as non- steroidal anti- inflammatory drugs. In men, the cause can be low sperm mobility, genetic factors, cystic fibrosis, diabetes, hypospadias, excess alcohol consumption, and other. Some of the common infertility test kits include luteinizing hormone (LH) urine test kits; human chorionic gonadotropin (HCG) hormone blood test kits and follicular stimulating hormone (FSH) urine test kits.

Access Full Report at https://www.databridgemarketresearch.com/reports/global-infertility-testing-market

Some of the factors which is responsible for the growth of Infertility Testing Market:

  • Medical tourism for fertility treatments: Medical tourism is where people living in one country move to another country for health, dental and surgical services while getting equal or greater care than they would in their own country. The main factor due to which patient are travelling to another is due to the high quality of healthcare, accessibility, access to services and better availability. There is also availability of advanced and developed technologies in different country at an affordable range
  • Increase in the rate of gynecological disorders: Gynecological are those conditions which are associated with the female reproductive system that unlikely to affect the chances of getting pregnant.  The main factor due to which there is increase in the gynecological disorder is changing lifestyle, degraded food quality, and stressful work environment. Some of the common gynecological disorders are PCOS, pelvic pain, uterine fibroids, urinary incontinent, pelvic floor prolapse, and menstrual disorders

Some of the launches and acquisition in the Infertility Testing Market are:

  • In October 2019, Predictive Laboratories announced the launch of their new FertilityDX which is genetic testing which recognizes obstacles to safe pregnancy and birth, allowing physicians to customize fertility treatments. FertilityDX gives information by analyzing three important areas that lead to causes of infertility, the risks of consequences of pregnancy, and the risks of severe offspring genetic conditions. They have the ability to support both patients and physician during treatment procedures
  • In September 2018, Mira announced the launch of their The Mira Fertility System which is specially designed for the women are unable to conceive. The Mira fertility system provides custom cycle forecasting by calculating levels of fertility hormones in urine samples, telling women what days they are fertile. These are considered to be more accurate as compared to the conventional tests kits. The woman puts the test strip in the machine to use the process and then uses immunofluorescence software to read the results

The global infertility testing market is segmented on the basis of type as female infertility testing, & male infertility testing; test kits as follicular stimulating hormone urine test kits, luteinizing hormone urine test kits, human chorionic gonadotropin hormone blood test kits, other test kits; prescription mode as prescription based, over the counter (OTC) based; distribution channel as hospitals pharmacies, online pharmacies, pharmacies & drug stores and end users as fertility centers, hospitals and clinics, research institutes, cryobanks.

“According to Data Bridge Market Research, Global Infertility Testing Market is set to witness a substantial of 7.30% in the forecast period of 2019- 2026”

Few of the major market competitors currently working in the global infertility testing market are Halotech DNA, Procter & Gamble, Andrology Solutions, SA Scientific, bioMérieux SA, Abbott, Quidel Corporation, Atlas Medical Uk, Babystart Ltd., SCSA Diagnostics, Gem Medic Technology Co. Ltd., Merck KGaA, bioZhena Corporation, Vitrolife, Progyny Inc., Ferring B.V., FUJIFILM Irvine Scientific, Genea Limited, Thermo Fisher Scientific, Siemens, Stryker, Metropolis India, CENTOGENE AG, Mayo Foundation for Medical Education and Research (MFMER), Dr Lal PathLabs among others.

Increasing cases of infertility and rising awareness among population about the infertility treatment are the factors which are affecting the market positively. The availability of advanced testing devices in the market is also expected to enhance the market growth.

Browse in Healthcare Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/